December 23, 2020 — The U.S. Food and Drug Administration December 18 issued an emergency use authorization (EUA) for a second vaccine for the prevention of coronavirus disease 2019 (COVID-19). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.
If you enjoy this content, please share it with a colleague
- Read more about FDA Approves Second COVID-19 Vaccine From Moderna
- Log in or register to post comments